ArticleFrontiers in medicine2026

INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice.

Sameer Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.